跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Amaramet - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Amaramet
Approved
STANDARD
Amaramet
Innova Captab Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
83326cec125bdbae
Company
Innova Captab Limited
Type
Standard
Approval Details
Approval Id
83326cec125bdbae
Drug Approval Philippines Name
Amaramet
Product Name
Amaramet
Registration Number
DRP-6696
Brand Name
Amaramet
Generic Name
Glimepiride + Metformin hydrochloride
Dosage Form
Extended-Release Tablet
Dosage Strength
2 mg/500 mg
Manufacturer
Innova Captab Limited
Importer
MedEthix, Inc.
Distributor
Corbridge Group Phils. Inc.
Issuance Date
26 March 2024
Expiry Date
26 March 2029
Pharmacologic Category
Oral Hypoglycemic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
83326cec125bdbae
Type
Standard
Back to Philippines FDA Approvals